Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain is a research paper published in The Ocular Surface (2021). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R61-NS113341
NINDS NIH HHS
Grant: R61 NS113341
NEI NIH HHS
Grant: R01 EY029602
National Institutes of Health
Grant: 1R61NS113341-01
Discovery of the Biomarker Signature for Neuropathic Corneal Pain
Lions Clubs International Foundation
Research to Prevent Blindness
Tufts Medical Center
Massachusetts Lions Eye Research Fund
FWCI
4.56
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals